Cargando…

Newer Antigens, Controls and Types in Complement, in the Serology of Syphilis, and Associated Considerations

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1951
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189309/ https://www.ncbi.nlm.nih.gov/pubmed/29014546

Ejemplares similares

Newer Antigens, Controls and Types in Complement, in the Serology of Syphilis, and Associated Considerations
Publicado: (1951)

Latent Syphilis in the Tropics
Publicado: (1938)

Serological Technique (Contd.)
Publicado: (1949)

Serological Technique (Contd.)
Publicado: (1949)

Serological Classification of C. Diphtheriae in Calcutta
Publicado: (1954)

Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13
por: Michael, Mini, et al.
Publicado: (2018)

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361–2369
por: Vaisar, Tomas, et al.
Publicado: (2019)

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
por: van Baar, Michaël J.B., et al.
Publicado: (2019)

B-Cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 2012;61:2893–2905
por: Mariño, E, et al.
Publicado: (2013)

Serological evaluation of antigen Tp0693 for diagnosis of syphilis
por: Zhang, Li, et al.
Publicado: (2017)

Erratum to: The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3
Publicado: (2021)

The Newer Treatments of Syphilis: Some Possible Sociological Effects
Publicado: (1913)

Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration: Erratum
Publicado: (2021)

Erratum. Elevated Serum Xanthine Oxidase Activity Is Associated With the Development of Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care 2018;41;884–890
por: Li, Xue, et al.
Publicado: (2019)

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002—1009
por: Anderson, Barbara J., et al.
Publicado: (2018)

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
por: Schernthaner, G, et al.
Publicado: (2013)

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Erratum. Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595—2602
por: Skinner, Sarah C., et al.
Publicado: (2019)

Erratum. The Transplantation of ω3 PUFA–Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. Diabetes 2018;67:1512–1523
por: Bidu, Célia, et al.
Publicado: (2019)

A STUDY OF COMPLEMENT FIXATION IN SYPHILIS WITH SPIROCHÆTA CULTURE ANTIGENS
por: Craig, Charles F., et al.
Publicado: (1912)

Erratum: The type-VI secretion system of the beneficial symbiont Vibrio fischeri
por: Guckes, Kirsten R., et al.
Publicado: (2023)

Shi CS, Shi GY, Hsiao SM, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 2008;112(9):3661-3670.
Publicado: (2013)

Erratum to: Complete genome sequence of Pirellula staleyi type strain (ATCC 27377(T))
por: Clum, Alicia, et al.
Publicado: (2010)

Erratum to: Complete genome sequence of Atopobium parvulum type strain (IPP 1246(T))
por: Copeland, Alex, et al.
Publicado: (2010)

Serological Tests for Syphilis
por: Cayton, H. R.
Publicado: (1966)

Serological tests for syphilis
por: Shah, Dhiral, et al.
Publicado: (2019)

Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607–615
por: Kovatchev, Boris, et al.
Publicado: (2020)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
por: Mita, Tomoya, et al.
Publicado: (2017)

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980
por: Aroda, Vanita R., et al.
Publicado: (2017)

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680
por: Ritzel, Robert, et al.
Publicado: (2019)

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035
por: Rosenstock, Julio, et al.
Publicado: (2017)

Erratum. Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes. Diabetes 2014;63:3835–3845
por: Arif, Sefina, et al.
Publicado: (2015)

Mature results from three large controlled studies with raltitrexed ('Toxudex')
Publicado: (1998)

Erratum. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2019;42:755–766
por: Jovanovski, Elena, et al.
Publicado: (2019)

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007;30:1581–1583
Publicado: (2013)

Erratum: PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity
por: Dabrowska, Aleksandra, et al.
Publicado: (2015)

Erratum: PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity
por: Dabrowska, Aleksandra, et al.
Publicado: (2016)

Erratum for “Proteinuria in dogs with gallbladder mucocele formation: A retrospective case control study”
Publicado: (2022)

Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232
por: Vora, J
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8qao92lcdta6lgembm62hifioa